A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Identifieur interne : 003E42 ( PubMed/Corpus ); précédent : 003E41; suivant : 003E43A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Auteurs : Matthew T. Ballo ; Gunar K. Zagars ; Jeffrey E. Gershenwald ; Jeffrey E. Lee ; Paul F. Mansfield ; Kevin B. Kim ; Luis H. Camacho ; Patrick Hwu ; Merrick I. RossSource :
- Annals of surgical oncology [ 1068-9265 ] ; 2004.
English descriptors
- KwdEn :
- Adult, Aged, Disease-Free Survival, Female, Humans, Lymphatic Metastasis (radiotherapy), Lymphedema (etiology), Male, Melanoma (pathology), Melanoma (radiotherapy), Melanoma (surgery), Middle Aged, Neoplasm Metastasis, Pelvis, Radiotherapy, Adjuvant, Retrospective Studies, Skin Neoplasms (pathology), Skin Neoplasms (radiotherapy), Skin Neoplasms (surgery), Treatment Outcome.
- MESH :
- etiology : Lymphedema.
- pathology : Melanoma, Skin Neoplasms.
- radiotherapy : Lymphatic Metastasis, Melanoma, Skin Neoplasms.
- surgery : Melanoma, Skin Neoplasms.
- Adult, Aged, Disease-Free Survival, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Pelvis, Radiotherapy, Adjuvant, Retrospective Studies, Treatment Outcome.
Abstract
Although patients with inguinal or pelvic lymph node (LN) metastases from melanoma may develop regional recurrence after dissection, the role of adjuvant radiotherapy remains controversial.
DOI: 10.1245/ASO.2004.12.039
PubMed: 15576833
Links to Exploration step
pubmed:15576833Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.</title><author><name sortKey="Ballo, Matthew T" sort="Ballo, Matthew T" uniqKey="Ballo M" first="Matthew T" last="Ballo">Matthew T. Ballo</name><affiliation><nlm:affiliation>Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. mballo@mdanderson.org</nlm:affiliation></affiliation></author><author><name sortKey="Zagars, Gunar K" sort="Zagars, Gunar K" uniqKey="Zagars G" first="Gunar K" last="Zagars">Gunar K. Zagars</name></author><author><name sortKey="Gershenwald, Jeffrey E" sort="Gershenwald, Jeffrey E" uniqKey="Gershenwald J" first="Jeffrey E" last="Gershenwald">Jeffrey E. Gershenwald</name></author><author><name sortKey="Lee, Jeffrey E" sort="Lee, Jeffrey E" uniqKey="Lee J" first="Jeffrey E" last="Lee">Jeffrey E. Lee</name></author><author><name sortKey="Mansfield, Paul F" sort="Mansfield, Paul F" uniqKey="Mansfield P" first="Paul F" last="Mansfield">Paul F. Mansfield</name></author><author><name sortKey="Kim, Kevin B" sort="Kim, Kevin B" uniqKey="Kim K" first="Kevin B" last="Kim">Kevin B. Kim</name></author><author><name sortKey="Camacho, Luis H" sort="Camacho, Luis H" uniqKey="Camacho L" first="Luis H" last="Camacho">Luis H. Camacho</name></author><author><name sortKey="Hwu, Patrick" sort="Hwu, Patrick" uniqKey="Hwu P" first="Patrick" last="Hwu">Patrick Hwu</name></author><author><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I" last="Ross">Merrick I. Ross</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15576833</idno><idno type="pmid">15576833</idno><idno type="doi">10.1245/ASO.2004.12.039</idno><idno type="wicri:Area/PubMed/Corpus">003E42</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003E42</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.</title><author><name sortKey="Ballo, Matthew T" sort="Ballo, Matthew T" uniqKey="Ballo M" first="Matthew T" last="Ballo">Matthew T. Ballo</name><affiliation><nlm:affiliation>Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. mballo@mdanderson.org</nlm:affiliation></affiliation></author><author><name sortKey="Zagars, Gunar K" sort="Zagars, Gunar K" uniqKey="Zagars G" first="Gunar K" last="Zagars">Gunar K. Zagars</name></author><author><name sortKey="Gershenwald, Jeffrey E" sort="Gershenwald, Jeffrey E" uniqKey="Gershenwald J" first="Jeffrey E" last="Gershenwald">Jeffrey E. Gershenwald</name></author><author><name sortKey="Lee, Jeffrey E" sort="Lee, Jeffrey E" uniqKey="Lee J" first="Jeffrey E" last="Lee">Jeffrey E. Lee</name></author><author><name sortKey="Mansfield, Paul F" sort="Mansfield, Paul F" uniqKey="Mansfield P" first="Paul F" last="Mansfield">Paul F. Mansfield</name></author><author><name sortKey="Kim, Kevin B" sort="Kim, Kevin B" uniqKey="Kim K" first="Kevin B" last="Kim">Kevin B. Kim</name></author><author><name sortKey="Camacho, Luis H" sort="Camacho, Luis H" uniqKey="Camacho L" first="Luis H" last="Camacho">Luis H. Camacho</name></author><author><name sortKey="Hwu, Patrick" sort="Hwu, Patrick" uniqKey="Hwu P" first="Patrick" last="Hwu">Patrick Hwu</name></author><author><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I" last="Ross">Merrick I. Ross</name></author></analytic><series><title level="j">Annals of surgical oncology</title><idno type="ISSN">1068-9265</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Disease-Free Survival</term><term>Female</term><term>Humans</term><term>Lymphatic Metastasis (radiotherapy)</term><term>Lymphedema (etiology)</term><term>Male</term><term>Melanoma (pathology)</term><term>Melanoma (radiotherapy)</term><term>Melanoma (surgery)</term><term>Middle Aged</term><term>Neoplasm Metastasis</term><term>Pelvis</term><term>Radiotherapy, Adjuvant</term><term>Retrospective Studies</term><term>Skin Neoplasms (pathology)</term><term>Skin Neoplasms (radiotherapy)</term><term>Skin Neoplasms (surgery)</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Lymphatic Metastasis</term><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Disease-Free Survival</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neoplasm Metastasis</term><term>Pelvis</term><term>Radiotherapy, Adjuvant</term><term>Retrospective Studies</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although patients with inguinal or pelvic lymph node (LN) metastases from melanoma may develop regional recurrence after dissection, the role of adjuvant radiotherapy remains controversial.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15576833</PMID><DateCreated><Year>2004</Year><Month>12</Month><Day>03</Day></DateCreated><DateCompleted><Year>2005</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2007</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1068-9265</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2004</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of surgical oncology</Title><ISOAbbreviation>Ann. Surg. Oncol.</ISOAbbreviation></Journal><ArticleTitle>A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.</ArticleTitle><Pagination><MedlinePgn>1079-84</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although patients with inguinal or pelvic lymph node (LN) metastases from melanoma may develop regional recurrence after dissection, the role of adjuvant radiotherapy remains controversial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The medical records of 40 patients with inguinal and/or pelvic lymph node metastases from melanoma were reviewed retrospectively. Indications for adjuvant radiotherapy included the following nodal characteristics: extracapsular extension, LNs > or =3 cm in diameter, > or =4 involved LNs, and LN recurrence after prior nodal surgery. Thirty-seven of 40 patients underwent formal LN dissection. Three patients had only local excision of gross disease for recurrence after prior dissection. All patients received radiation to a median dose of 30 Gy at six Gy/fraction delivered twice weekly.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">With a median follow-up time of 22.5 months, the 3-year actuarial distant metastasis-free and overall survival rates were 35% and 38%, respectively. The 3-year regional control rate was 74%. Univariate analyses of patient, tumor, and treatment characteristics failed to reveal any association with distant metastasis-free survival, overall survival, or regional control. Regional failures occurred in nine patients; seven of these were isolated dermal failures within the field of irradiation. Only two patients (5%) had LN basin recurrences; one of these patients also developed dermal recurrence. Fifteen of 40 patients developed lymphedema; in seven of these, lymphedema was present before initiation of radiation therapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Radiation may prevent recurrence of nodal disease in patients at high risk for regional failure, but in-field dermal recurrences may sometimes occur (8 of 40, 20%). Treatment-related lymphedema and death from metastatic melanoma were common.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ballo</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. mballo@mdanderson.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zagars</LastName><ForeName>Gunar K</ForeName><Initials>GK</Initials></Author><Author ValidYN="Y"><LastName>Gershenwald</LastName><ForeName>Jeffrey E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jeffrey E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Mansfield</LastName><ForeName>Paul F</ForeName><Initials>PF</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kevin B</ForeName><Initials>KB</Initials></Author><Author ValidYN="Y"><LastName>Camacho</LastName><ForeName>Luis H</ForeName><Initials>LH</Initials></Author><Author ValidYN="Y"><LastName>Hwu</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Merrick I</ForeName><Initials>MI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg Oncol</MedlineTA><NlmUniqueID>9420840</NlmUniqueID><ISSNLinking>1068-9265</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010388" MajorTopicYN="N">Pelvis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>12</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>3</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>12</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15576833</ArticleId><ArticleId IdType="pii">11/12/1079</ArticleId><ArticleId IdType="doi">10.1245/ASO.2004.12.039</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E42 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003E42 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:15576833
|texte= A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15576833" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |